Lind, Hanne
Gameiro, Sofia R
Jochems, Caroline
Donahue, Renee N.
Strauss, Julius
Gulley, James L MD, http://orcid.org/0000-0002-6569-2912
Palena, Claudia
Schlom, Jeffrey
Clinical trials referenced in this document:
Documents that mention this clinical trial
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
https://doi.org/10.1371/journal.pone.0090353
Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
https://doi.org/10.1136/jitc-2019-000433
Funding for this research was provided by:
National Cancer Institute (ZIA BC 010425, ZIA BC 010944)